Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review

The MedLine database contains 570 publications, including 71 randomized clinical trials and 6 meta-analyses on the rebamipide molecule in 2022. Indications for the use of rebamipide are gastric ulcer, chronic gastritis with hyperacidityin the acute stage, erosive gastritis, prevention of damage to t...

Full description

Bibliographic Details
Main Authors: Natalia V. Bakulina, Sergey V. Tikhonov, Sergey V. Okovityi, Elena A. Lutaenko, Alexandеr O. Bolshakov, Veronika A. Prikhodko, Anna S. Nekrasova
Format: Article
Language:Russian
Published: "Consilium Medicum" Publishing house 2023-01-01
Series:Терапевтический архив
Subjects:
Online Access:https://ter-arkhiv.ru/0040-3660/article/viewFile/121855/96715
_version_ 1797846631709671424
author Natalia V. Bakulina
Sergey V. Tikhonov
Sergey V. Okovityi
Elena A. Lutaenko
Alexandеr O. Bolshakov
Veronika A. Prikhodko
Anna S. Nekrasova
author_facet Natalia V. Bakulina
Sergey V. Tikhonov
Sergey V. Okovityi
Elena A. Lutaenko
Alexandеr O. Bolshakov
Veronika A. Prikhodko
Anna S. Nekrasova
author_sort Natalia V. Bakulina
collection DOAJ
description The MedLine database contains 570 publications, including 71 randomized clinical trials and 6 meta-analyses on the rebamipide molecule in 2022. Indications for the use of rebamipide are gastric ulcer, chronic gastritis with hyperacidityin the acute stage, erosive gastritis, prevention of damage to the gastrointestinal mucosa while taking non-steroidal anti-inflammatory drugs, eradication of Helicobacter pylori. Currently trials are studying the efficacy and safety of the drug in gouty and rheumatoid arthritis, osteoarthritis, Sjgren's syndrome, bronchial asthma, vitiligo, atherosclerosis, diseases of the kidneys and liver; using in traumatology to accelerate bone regeneration; in ophthalmology to improve the regeneration of corneal epithelium; in oncology to reduce inflammatory changes in the oral mucosa after chemoradiotherapy. The review article is about the main pharmacokinetic and pharmacodynamic characteristics of rebamipide. A detailed understanding of pharmacodynamics and pharmacokinetics allows for individual selection of therapy based on the characteristics of the patient's body gender, age, comorbidities; choose the optimal route of administration and dosing regimen; predict adverse effects and drug interactions; be determined with new clinical indications.
first_indexed 2024-04-09T17:58:05Z
format Article
id doaj.art-854065ccdd4f4d0788bc00d7afd90d2c
institution Directory Open Access Journal
issn 0040-3660
2309-5342
language Russian
last_indexed 2024-04-09T17:58:05Z
publishDate 2023-01-01
publisher "Consilium Medicum" Publishing house
record_format Article
series Терапевтический архив
spelling doaj.art-854065ccdd4f4d0788bc00d7afd90d2c2023-04-14T13:31:51Zrus"Consilium Medicum" Publishing houseТерапевтический архив0040-36602309-53422023-01-0194121431143710.26442/00403660.2022.12.20200078236Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A reviewNatalia V. Bakulina0https://orcid.org/0000-0003-4075-4096Sergey V. Tikhonov1https://orcid.org/0000-0001-5720-3528Sergey V. Okovityi2https://orcid.org/0000-0003-4294-5531Elena A. Lutaenko3https://orcid.org/0000-0003-3472-3728Alexandеr O. Bolshakov4https://orcid.org/0000-0002-5103-5778Veronika A. Prikhodko5https://orcid.org/0000-0002-4690-1811Anna S. Nekrasova6https://orcid.org/0000-0001-5198-9902Mechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversitySaint Petersburg State Chemical Pharmaceutical UniversityMechnikov North-Western State Medical UniversityMechnikov North-Western State Medical UniversitySaint Petersburg State Chemical Pharmaceutical UniversityMechnikov North-Western State Medical UniversityThe MedLine database contains 570 publications, including 71 randomized clinical trials and 6 meta-analyses on the rebamipide molecule in 2022. Indications for the use of rebamipide are gastric ulcer, chronic gastritis with hyperacidityin the acute stage, erosive gastritis, prevention of damage to the gastrointestinal mucosa while taking non-steroidal anti-inflammatory drugs, eradication of Helicobacter pylori. Currently trials are studying the efficacy and safety of the drug in gouty and rheumatoid arthritis, osteoarthritis, Sjgren's syndrome, bronchial asthma, vitiligo, atherosclerosis, diseases of the kidneys and liver; using in traumatology to accelerate bone regeneration; in ophthalmology to improve the regeneration of corneal epithelium; in oncology to reduce inflammatory changes in the oral mucosa after chemoradiotherapy. The review article is about the main pharmacokinetic and pharmacodynamic characteristics of rebamipide. A detailed understanding of pharmacodynamics and pharmacokinetics allows for individual selection of therapy based on the characteristics of the patient's body gender, age, comorbidities; choose the optimal route of administration and dosing regimen; predict adverse effects and drug interactions; be determined with new clinical indications.https://ter-arkhiv.ru/0040-3660/article/viewFile/121855/96715rebamipidepharmacokineticspharmacodynamicsabsorptionfirst pass metabolismbioavailabilityprotein bindingvolume of distributionmetabolismexcretion
spellingShingle Natalia V. Bakulina
Sergey V. Tikhonov
Sergey V. Okovityi
Elena A. Lutaenko
Alexandеr O. Bolshakov
Veronika A. Prikhodko
Anna S. Nekrasova
Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
Терапевтический архив
rebamipide
pharmacokinetics
pharmacodynamics
absorption
first pass metabolism
bioavailability
protein binding
volume of distribution
metabolism
excretion
title Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
title_full Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
title_fullStr Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
title_full_unstemmed Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
title_short Pharmacokinetics and pharmacodynamics of rebamipide. New possibilities of therapy: A review
title_sort pharmacokinetics and pharmacodynamics of rebamipide new possibilities of therapy a review
topic rebamipide
pharmacokinetics
pharmacodynamics
absorption
first pass metabolism
bioavailability
protein binding
volume of distribution
metabolism
excretion
url https://ter-arkhiv.ru/0040-3660/article/viewFile/121855/96715
work_keys_str_mv AT nataliavbakulina pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT sergeyvtikhonov pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT sergeyvokovityi pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT elenaalutaenko pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT alexanderobolshakov pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT veronikaaprikhodko pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview
AT annasnekrasova pharmacokineticsandpharmacodynamicsofrebamipidenewpossibilitiesoftherapyareview